麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

上海非利加實業有限公司Logo

熱門詞: 進口電動溫度調節閥結構圖|進口電動溫度調節閥數據表進口電動高溫調節閥-德國進口電動高溫法蘭調節閥進口電動蒸汽調節閥-德國進口電動蒸汽調節閥

當前位置: 首頁 > 所有品牌 > Calixa Therapeutics
Calixa Therapeutics
Calixa Therapeutics Calixa Therapeutics

美國Calixa Therapeutics 
Calixa Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of a novel cephalosporin to address the expanding problem of multi-drug resistant organisms. Treatment of infections caused by resistant gram-negative bacteria, especially Pseudomonas aeruginosa, is recognized as an unmet medical need by the infectious diseases community.
Calixa’s lead product, CXA-101, is an IV formulation of a novel cephalosporin that has excellent potency especially against multi-drug resistant Pseudomonas aeruginosa, which differentiates it from other cephalosporins. No similar drug is known to be in development. Calixa plans to combine this product with a β-lactamase inhibitor; the combination product (CXA-201) has the potential to become the first-line therapeutic choice for hospitalized patients suffering from serious infection caused by gram-negative organisms.
DEVELOPMENT STATUSThe IND for CXA-101 was filed in June 2008, and two Phase 1 studies were successfully completed by January 2009. The safety and pharmacokinetic profile of CXA-101 was excellent. A Phase 2 study in complicated urinary tract infection was initiated in the second quarter of 2009. The development pathway of CXA-101 will be merged with the development of CXA-201, the combination of CXA-101 and a β-lactamase inhibitor. CXA-201 has an enhanced spectrum of activity and therefore high potential clinical utility as first-line therapy for serious gram-negative infection in hospitalized patients. In addition to the IV products, the same cephalosporin is being evaluated for inhaled administration (the CXA-301 program) in cystic fibrosis patients to address multi-drug resistance (including to tobramycin) in Pseudomonas aeruginosa infections.
HISTORYCalixa was cofounded in 2007 by Drs. Eckard Weber and James Ge. Calixa successfully acquired the global (excluding certain Asia-Pacific territories) development rights for FR264205 from Astellas Pharma Inc. Calixa quickly assembled a management team with extensive recent experience in the clinical development of anti-infectives. We raised a $30 million Series A round from three highly respected venture capital firms: Domain Associates, Canaan Partners and Frazier Healthcare Ventures.
 

關于我們客戶服務產品分類法律聲明
主站蜘蛛池模板: 丰满日韩放荡少妇无码视频 | 肉小说污肉| 国产精品一区二区三区99性 | 日本人妖一区视频 | 日韩欧美不卡一二三区 | 日韩伦理在线免费观看 | 久久精品国产亚洲AV波多 | 99久久中文字幕 | 美女大战巨茎黑人 | 国产精品露脸国语对白 | 成人免费20242024被爆出 | 99久久人妻无码精品系列蜜桃 | 麻豆tv传媒免费网址 | 99精品国产一区二区三区不卡 | 亚洲国产欧美国产第一区二区 | 麻豆午夜区吴梦 | 亚洲精品无码久久久久久 | 精品国产人妻一区二区三区久久 | 亚洲欧美日韩在线不卡中文 | 久久天天躁狠狠躁夜夜躁 | 亚洲AV国产AV一区无码小说 | 国产精品久久久久久久久久 | 国产精品出奶水一区二区三区 | 素人约啪第五季 | 日韩欧美在线观看成人日韩福利在线 | 成人性生交A片免费网 | 99国产精品久久人妻无码 | 美女高潮无套 | 亚洲欧美日韩一区 | 国产欧洲野花视频WWW | 亚洲岛国在线观看一区二区三区 | 成人国产精品日本在线观看 | 97蜜桃小说及图片 | 波多野结衣人妻渴望A片 | 国产精品路线1路线2路线 | 麻豆自制传媒 最新网站 | 成人无码在线观看亚洲 | 少妇大叫又粗又大太爽A片 少妇高潮惨叫久久久久久欧美 | 日本aⅴ在线 | 国产婷婷色综合av蜜臀av | 国产精品人妻无码免费A片导航 |